Resultados da busca - Nedelman, Jerry

On some “disadvantages” of the population approach por Nedelman, Jerry R.

Obter o texto integral Obter o texto integral Obter o texto integral

Population Pharmacokinetics of the Antituberculosis Agent Pretomanid por Salinger, David H., Subramoney, Vishak, Everitt, Daniel, Nedelman, Jerry R.

Obter o texto integral Obter o texto integral Obter o texto integral

Single Ascending-Dose Study To Evaluate the Safety, Tolerability, and Pharmacokinetics of Sutezolid in Healthy Adult Subjects por Bruinenberg, Paul, Nedelman, Jerry, Yang, Tian J., Pappas, Fran, Everitt, Dan

Obter o texto integral Obter o texto integral Obter o texto integral

Proposed Linezolid Dosing Strategies to Minimize Adverse Events for Treatment of Extensively Drug-Resistant Tuberculosis por Imperial, Marjorie Z, Nedelman, Jerry R, Conradie, Francesca, Savic, R M

Obter o texto integral Obter o texto integral Obter o texto integral

Population pharmacokinetics of intravenous and oral panobinostat in patients with hematologic and solid tumors por Savelieva, Marina, Woo, Margaret M., Schran, Horst, Mu, Song, Nedelman, Jerry, Capdeville, Renaud

Obter o texto integral Obter o texto integral Obter o texto integral

Daily Dosing for Bedaquiline in Patients with Tuberculosis por Salinger, David H., Nedelman, Jerry R., Mendel, Carl, Spigelman, Melvin, Hermann, David J.

Obter o texto integral Obter o texto integral Obter o texto integral

Correlating changes in lung function with patient outcomes in chronic obstructive pulmonary disease: a pooled analysis por Jones, Paul W, Donohue, James F, Nedelman, Jerry, Pascoe, Steve, Pinault, Gregory, Lassen, Cheryl

Obter o texto integral Obter o texto integral Obter o texto integral

Long-Term Effects on QT Prolongation of Pretomanid Alone and in Combinations in Patients with Tuberculosis por Li, Hanbin, Salinger, David H., Everitt, Daniel, Li, Mengchun, Del Parigi, Angelo, Mendel, Carl, Nedelman, Jerry R.

Obter o texto integral Obter o texto integral Obter o texto integral

Phase 1 Study of the Effects of the Tuberculosis Treatment Pretomanid, Alone and in Combination With Moxifloxacin, on the QTc Interval in Healthy Volunteers por Li, Mengchun, Saviolakis, George A., El‐Amin, Wael, Makhene, Mamodikoe K., Osborn, Blaire, Nedelman, Jerry, Yang, Tian J., Everitt, Daniel

Obter o texto integral Obter o texto integral Obter o texto integral

An Exposure-Response Perspective on the Clinical Dose of Pretomanid por Nedelman, Jerry R., Salinger, David H., Subramoney, Vishak, Woolson, Rob, Wade, Karen, Li, Mengchun, Everitt, Daniel, Mendel, Carl M., Spigelman, Mel

Obter o texto integral Obter o texto integral Obter o texto integral

Fourteen-Day Bactericidal Activity, Safety, and Pharmacokinetics of Linezolid in Adults with Drug-Sensitive Pulmonary Tuberculosis por Diacon, Andreas H., De Jager, Veronique R., Dawson, Rodney, Narunsky, Kim, Vanker, Naadira, Burger, Divan A., Everitt, Daniel, Pappas, Frances, Nedelman, Jerry, Mendel, Carl M.

Obter o texto integral Obter o texto integral Obter o texto integral

Reply to Kim et al., “Optimal Dose or Optimal Exposure? Consideration for Linezolid in Tuberculosis Treatment” por Diacon, Andreas H., De Jager, Veronique R., Dawson, Rodney, Narunsky, Kim, Vanker, Naadira, Burger, Divan A., Everitt, Daniel, Pappas, Frances, Nedelman, Jerry, Mendel, Carl M.

Obter o texto integral Obter o texto integral Obter o texto integral